MURRAY RICHARD /CA/ (CEO and President) sold 16.7% of their position (37.29K shares) of JOUNCE THERAPEUTICS, INC. on the open market
Open‑market sale worth $256.7K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/11/2022ACC: 0001640455-22-000010
DirectorOfficer· CEO and President
Since Sep 2018
-37.29K
Net shares
Net seller
$256.7K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
37.29K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−13.37K
Price / share
$7.30
Trade value
$97.60K
% of position
6.0%
1/7/2022
222.87K→209.50K
Common Stock
Direct
Shares
−23.92K
Price / share
$6.65
Trade value
$159.09K
% of position
11.4%
1/10/2022
209.50K→185.58K
Total
Net shares
−37.29K
Net value
-$256.70K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/7/2022 | S · Sale | −13.37K | $7.30 | $97.60K | 6.0% | 222.87K | 209.50K |
| Common Stock Direct | 1/10/2022 | S · Sale | −23.92K | $6.65 | $159.09K | 11.4% | 209.50K | 185.58K |
| Total | −37.29K | -$256.70K | ||||||
Derivative Transactions0
No derivative transactions reported